Radium-223 dichloride (xofigo)
Ended Awarded Last action
- Contract number
- 36C25021N0107
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $43,964
Award facts
- Contract value 100% obligated
- $43,964.15 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Indianapolis, IN 46202, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$165,834 | |
| Original award | $209,798 |
About this award
This firm fixed price contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 to Bayer Healthcare Pharmaceuticals Inc. for the delivery of radium-223 dichloride (Xofigo), a pharmaceutical drug. With a potential value of $43,964.15, the contract utilizes the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has a period of performance through September 30, 2024. To be delivered to the place of performance in Indianapolis, Indiana, the radium-223 dichloride will support the treatment programs of VISN 10 in providing healthcare services to veterans. No set-aside designation was applied to this contract award.
Quick answers
Who was awarded contract 36C25021N0107?
36C25021N0107 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2020.
How much is contract 36C25021N0107 worth?
The government has obligated $43,964 on 36C25021N0107.
Is contract 36C25021N0107 an order under another contract?
Yes. 36C25021N0107 is a BPA call under V797P2202D-36C25020A0024, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25021N0107 competed?
The extent of competition for 36C25021N0107 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award